Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety of Pemafibrate, a Novel Selective PPARα Modulator in Chinese Patients with Dyslipidemia: A Double-Masked, Randomized, Placebo- and Active-Controlled Comparison Trial

Wenli Dai,Qiang Lv, Qingling Li,Lu Fu,Yawei Zhang,Yumin Zhang, Lijun Liu,Ryohei Tanigawa, Keisuke Kunitomi,Ryo Kamei,Hideki Suganami,Changsheng Ma

Journal of atherosclerosis and thrombosis（2024）

Cited 0|Views6
Key words
Pemafibrate,Selective PPAR modulator,Clinical trial,Dyslipidemia,Triglyceride
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined